97 related articles for article (PubMed ID: 20359711)
1. Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan.
Wang CH; Chen CJ; Lee MH; Yang HI; Hsiao CK
Atherosclerosis; 2010 Aug; 211(2):624-9. PubMed ID: 20359711
[TBL] [Abstract][Full Text] [Related]
2. Risk and predictors of mortality associated with chronic hepatitis B infection.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
[TBL] [Abstract][Full Text] [Related]
3. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
[TBL] [Abstract][Full Text] [Related]
4. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan.
Fwu CW; Chien YC; Nelson KE; Kirk GD; You SL; Kuo HS; Feinleib M; Chen CJ
J Infect Dis; 2010 Apr; 201(7):1016-23. PubMed ID: 20187745
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction.
Sung J; Song YM; Choi YH; Ebrahim S; Davey Smith G
Stroke; 2007 May; 38(5):1436-41. PubMed ID: 17379829
[TBL] [Abstract][Full Text] [Related]
6. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.
Tai DI; Tsay PK; Chen WT; Chu CM; Liaw YF
Am J Gastroenterol; 2010 May; 105(5):1102-9. PubMed ID: 20197760
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese.
Yang KC; Chen MF; Su TC; Jeng JS; Hwang BS; Lin LY; Liau CS; Lee YT
Atherosclerosis; 2007 Dec; 195(2):392-7. PubMed ID: 17134707
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
10. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up.
Chu CM; Liaw YF
Hepatology; 2007 May; 45(5):1187-92. PubMed ID: 17465003
[TBL] [Abstract][Full Text] [Related]
11. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Lu SN; Chen CJ
Liver Int; 2010 Mar; 30(3):423-9. PubMed ID: 19840258
[TBL] [Abstract][Full Text] [Related]
12. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
14. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846
[TBL] [Abstract][Full Text] [Related]
15. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the natural decay of hepatitis B surface antigen in children with chronic hepatitis B virus infection during long-term follow-up.
Chiu YC; Liao SF; Wu JF; Lin CY; Lee WC; Chen HL; Ni YH; Hsu HY; Chang MH
J Pediatr; 2014 Oct; 165(4):767-72.e1. PubMed ID: 25112693
[TBL] [Abstract][Full Text] [Related]
18. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
Moucari R; Korevaar A; Lada O; Martinot-Peignoux M; Boyer N; Mackiewicz V; Dauvergne A; Cardoso AC; Asselah T; Nicolas-Chanoine MH; Vidaud M; Valla D; Bedossa P; Marcellin P
J Hepatol; 2009 Jun; 50(6):1084-92. PubMed ID: 19376603
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
Tseng TC; Liu CJ; Su TH; Wang CC; Chen CL; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2011 Aug; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.
Yap DY; Tang CS; Yung S; Choy BY; Yuen MF; Chan TM
Transplantation; 2010 Aug; 90(3):325-30. PubMed ID: 20562676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
